1 developer-"https:"-"https:"-"https:"-"UCL" positions at Université de Bordeaux

DÉVELOPPEMENT DE NANOBODIES THÉRAPEUTIQUES CIBLANT LE RÉCEPTEUR GUANYLYL CYCLASE C // DEVELOPMENT OF THERAPEUTIC NANOBODIES TARGETING THE GUANYLYL CYCLASE C RECEPTOR.

Université de Bordeaux | Pessac, Aquitaine | France | 2 days ago

target for therapeutic intervention. This PhD project aims to develop nanobodies - single domain antibodies derived from camelid immunoglobulins - targeting GC-C for both therapeutic and structural